References
- Bourke SC, Shaw PJ, Gibson GJ. Respiratory function vs sleep- disordered breathing as predictors of QOL in ALS. Neurology 2001; 57: 2040–2044.
- Gay PC, Westbrook PR, Daube JR et al. Effects of alterations in pulmonary function and sleep variables on survival in patients with amyotrophic lateral sclerosis. Mayo Clin Proc 1991; 66: 686–694.
- Pinto AC, Evangelista T, Carvalho M et al. Respiratory assistance with a non-invasive ventilator (Bipap) in MND/ALS patients: Survival rates in a controlled trial. J Neurol Sci 1995; 129(Suppl): 19–26.
- Aboussouan LS, Khan SU, Meeker DP et al. Effect of noninvasive positive-pressure ventilation on survival in amyotrophic lateral sclerosis. Ann Intern Med 1997; 127: 450–453.
- Kleopa KA, Sherman M, Neal B et al. Bipap improves survival and rate of pulmonary function decline in patients with ALS. J Neurol Sci 1999; 164: 82–88.
- Hein H, Schucher B, Magnussen H. Intermittent assisted ventilation in neuromuscular diseases: course and quality of life. Pneumologie 1999; 53(suppl 2): S89–90.
- Lyall RA, Donaldson N, Fleming T et al. A prospective study of quality of life in ALS patients treated with non-invasive ventilation. Neurology 2001; 57: 153–156.
- Aboussouan LS, Khan SU, Banerjee M et al. Objective mea- sures of the efficacy of noninvasive positive-pressure ventilation in amyotrophic lateral sclerosis. Muscle Nerve 2001; 24: 403–409.
- Ware JE, Snow KK, Kosinski M et al. SF-36 Health survey: Manual and interpretation Guide. Boston, Massachusetts: The Health Institute, New England Medical Centre, 1993.
- Jenkinson C, Layte R, Wright L, Coulter A. The UK SF-36: An analysis and Interpretation Manual. Oxford: Health Services Research Unit, University of Oxford, 1996.
- Dupuy HJ. Assessment of Quality of Life in Clinical Trials for Cardiovascular Therapies. New York: LeJacq, 1984.
- Guyatt GH, Berman LB, Townsend M et al. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42: 773–778.
- Flemons WW, Reimer MA. Development of a disease-specific health-related quality of life questionnaire for sleep apnoea. Am J Respir Crit Care Med 1998; 158: 494–503.
- Johns MW. Sleepiness in different situations measured by the Epworth Sleepiness Scale. Sleep 1994; 17: 703–710.
- Shields RK, Ruhland JL, Ross MA et al. Analysis of health-related quality of life and muscle impairment in individuals with amyotrophic lateral sclerosis using the medical outcome survey and the Tufts Quantitative Neuromuscular Exam. Arch Phys Med Rehabil 1998; 79: 855–862.
- Fazio A. A concurrent validation study of the NCHS General Well-being Schedule. Hyattsville, MD: U.S. Department of Health, Education and Welfare, National Centre for Health Statistics, 1977: 78–1347.
- Brooks BR, Sanjak M, Ringel S et al. The amyotrophic lateral sclerosis functional rating scale: assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol 1996; 53: 141–147.
- Wilson SH, Cooke NT, Edwards RHT, Spiro SG. Predicted normal values for maximal respiratory pressures in Caucasian adults and children. Thorax 1984; 39: 535–538.
- Bensimon G, Lacomblez L, Meninger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 1994; 330: 585–91.
- Fitzpatrick R, Davey C, Buxton MJ, Jones DR. Evaluating patient- based outcome measures for use in clinical trials. Health Technol Assess 1998; 2: 1–69.
- Campbell DT, Fiske DW. Convergent and discriminant validation by the multitrait-multimethod matrix. Psychol Bull 1959; 56: 81.
- McDowell I, Newell C. Measuring health: a guide to rating scales and questionnaires. Oxford: Oxford University Press, 1987.
- Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. Oxford: Oxford University Press, 1989.
- Fayers PM, Machin D. Quality of life: assessment, analysis and interpretation. Chichester: John Wiley and Sons, Inc, 2000.
- Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989; 27 (suppl): S178–89.
- Jenkinson C, Stewart-Brown S, Petersen S, Paice C. Assessment of the SF-36 version 2 in the United Kingdom. J Epidemiol Community Health 1999; 53: 46–50.
- Edwards DW, Yaris RM, Mueller DP. Test-taking and the stability of assessment scales: can we assess patient deterioration?. Evaluation Q 1978; 2: 275–291.